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The systemic reaction to acute inflammation, also known as acute phase response, 
induces some hemato-biochemical changes, which can be evidenced in laboratory 
findings. The C Reactive Protein (CRP) is a main acute phase response protein elective in 
dogs to detect inflammatory disease. Other blood parameters have been described as 
useful inflammation markers i.e. Fibrinogen and Leukocytes (1, 2, 3). 
The aim of this retrospective study was to investigate the CRP values in comparison to 
Fibrinogen (Fib), Albumin (Alb), and Iron (Fe) values, total White Blood Cell (WBC), 
Segmented Neutrophil (NeuSeg) and Band Neutrophil (Band) counts, and the occurrence 
of Toxic Neutrophils (Neu TOX), Activated Monocytes (Mon ATT), and Reactive 
Lymphocytes (Linf REA) in blood smears. 
For this purpose, data of 1,837 blood samples was collected over a three-year period 
(2012-2015). Data collected for each sample included: Fib, Alb, Fe, WBC, NeuSeg, Band, 
Neu TOX, Mon ATT, Linf REA and CRP, as well as information regarding dog’s age, breed, 
and gender. 
Blood samples were divided into 2 groups: "inflammatory";; CRP ≥0.30 mg/dL (#1080) 
and non-inflammatory;; CRP ≤0.29 mg/dL (#757). The 2 groups were compared using: 
Chi squared for sex, breed, and age; Relative risk (RR) for age; Spearman Rank 
correlation test (SRct) for all parameters studied; Multiple regression (MR) to assess the 
relationship between CRP and other inflammation markers; Receiver Operating 
Characteristic (ROC) curves for diagnostic accuracy of each parameter in comparison to 
CRP (MedCalc®, 14.8). Dogs belonging to inflammatory group were significantly older (>7 
years old) than those of non-inflammatory group (P<0.05), (RR, 1.38). Low yet significant 
(p<0.01) correlations between CRP and the other markers were noted using the SRct (R): 
CRP/Fib, +0.26; CRP/NeuSeg, +0.26; CRP/WBC, +0.24; CRP/Alb, -0.21; CRP/Band, 
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+0.14; CRP/Fe, -0.08; CRP/NeuTOX, +0.23; MonATT, +0.22. On the contrary, the MR 
analysis did not show any relationship between CRP and other markers (R2: 0.05 for 
CRP ≥ 0.30 mg/dL;; 0.02 for CRP ≤ 0.29 mg/dL). ROC analysis of the parameters yielded 
the following results: NeuSeg is a moderately accurate inflammation marker with Area 
Under the Curve (AUC) of 0.71. The other parameters are less accurate markers of 
inflammation (AUC) compared to CRP: WBC, 0.70; Fib, 0.67; Alb, 0.64; Fe, 0.64; Band, 
0.59. The markers with the best combination of Sensitivity (SS) and Specificity (SP) were: 
Fib (SS, 52.7; SP, 77.5 for 400 mg/dL cut-off) and Band (SS, 17.6; SP, 98.0 for 0.3 K/µL 
cut-off). The correlation between CRP and all the parameters studied, except Linf REA, is 
significant but low because they are affected by many conditions aside from 
inflammation. None of them is able to predict CRP values. The diagnostic accuracy of 
each single inflammatory marker is lower in comparison to CRP. In order to increase the 
diagnostic accuracy of inflammation markers, an evaluation of several parameters 
simultaneously is warranted, particularly in the absence of CRP measurement.  
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